Intercept Pharmaceuticals
Daniel Roush is an accomplished professional with extensive experience in pharmaceutical and medical sales, currently serving as a Senior Territory Business Manager specializing in Rare Liver Disease at Intercept Pharmaceuticals since October 2021. Recognized with the 2024 Core Value Award for the Northeast Region, Daniel ranks 4th nationally out of 60 and has demonstrated consistent performance throughout a successful career, including a prior role as a Territory Business Manager with multiple national rankings and awards. Previous experience includes positions at Abbott Diabetes Care, Actavis plc, Stryker, and Abbott Laboratories, complemented by a background in nursing as an Emergency Room Registered Nurse. Daniel holds a Bachelor of Science in Education from the State University of New York at Fredonia and an Associate of Applied Science in Nursing from Jamestown Community College.
This person is not in any teams
This person is not in any offices
Intercept Pharmaceuticals
1 followers
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.